ClinicalTrials.gov record
Completed Phase 3 Interventional

Topical Anesthetic for Procedures Through the Nose

ClinicalTrials.gov ID: NCT02667054

Public ClinicalTrials.gov record NCT02667054. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Investigation Of Topical Application Of RX0041-002 On Safety And Efficacy In Local (Topical) Anesthesia For Diagnostic Procedures And Surgeries On Or Through The Accessible Mucous Membranes Of The Nasal Cavities

Study identification

NCT ID
NCT02667054
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Pharmaceutical Project Solutions, Inc.
Industry
Enrollment
648 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • RX0041 4% Drug
  • RX0041 8% Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2014
Primary completion
Nov 30, 2015
Completion
Dec 31, 2015
Last update posted
May 16, 2016

2014 – 2016

United States locations

U.S. sites
2
U.S. states
2
U.S. cities
2
Facility City State ZIP Site status
Aroesty Advocare ENT Mount Arlington New Jersey 07856
South Carolina ENT Columbia South Carolina 29203

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02667054, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2016 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02667054 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →